nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—ABCB1—peripheral nervous system neoplasm	0.21	1	CbGaD
Phenytoin—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.101	0.185	CbGbCtD
Phenytoin—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0335	0.0616	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0335	0.0616	CbGbCtD
Phenytoin—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0319	0.0586	CbGbCtD
Phenytoin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0251	0.0462	CbGbCtD
Phenytoin—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0444	CbGbCtD
Phenytoin—ABCC2—Vincristine—peripheral nervous system neoplasm	0.023	0.0423	CbGbCtD
Phenytoin—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0215	0.0395	CbGbCtD
Phenytoin—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0211	0.0388	CbGbCtD
Phenytoin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0176	0.0323	CbGbCtD
Phenytoin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0176	0.0323	CbGbCtD
Phenytoin—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0169	0.031	CbGbCtD
Phenytoin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0154	0.0283	CbGbCtD
Phenytoin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0154	0.0283	CbGbCtD
Phenytoin—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0144	0.0265	CbGbCtD
Phenytoin—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0137	0.0251	CbGbCtD
Phenytoin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0122	0.0224	CbGbCtD
Phenytoin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0115	0.0212	CbGbCtD
Phenytoin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0106	0.0194	CbGbCtD
Phenytoin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0105	0.0194	CbGbCtD
Phenytoin—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0102	0.0187	CbGbCtD
Phenytoin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0098	0.018	CbGbCtD
Phenytoin—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00916	0.0168	CbGbCtD
Phenytoin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00751	0.0138	CbGbCtD
Phenytoin—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00722	0.0133	CbGbCtD
Phenytoin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00701	0.0129	CbGbCtD
Phenytoin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00688	0.0126	CbGbCtD
Phenytoin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00469	0.00862	CbGbCtD
Phenytoin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0045	0.00827	CbGbCtD
Phenytoin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00412	0.00758	CbGbCtD
Phenytoin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00281	0.00517	CbGbCtD
Phenytoin—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.00147	0.437	CbGeAlD
Phenytoin—SCN8A—nerve—peripheral nervous system neoplasm	0.000466	0.138	CbGeAlD
Phenytoin—SLCO1C1—ganglion—peripheral nervous system neoplasm	0.000392	0.116	CbGeAlD
Phenytoin—SCN8A—brainstem—peripheral nervous system neoplasm	0.0002	0.0592	CbGeAlD
Phenytoin—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.000199	0.0588	CbGeAlD
Phenytoin—SCN1A—brainstem—peripheral nervous system neoplasm	0.000151	0.0448	CbGeAlD
Phenytoin—SCN2A—brainstem—peripheral nervous system neoplasm	0.000139	0.0411	CbGeAlD
Phenytoin—SCN8A—cerebellum—peripheral nervous system neoplasm	9.86e-05	0.0292	CbGeAlD
Phenytoin—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.44e-05	0.000395	CcSEcCtD
Phenytoin—Infection—Etoposide—peripheral nervous system neoplasm	8.43e-05	0.000395	CcSEcCtD
Phenytoin—Ataxia—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000394	CcSEcCtD
Phenytoin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.41e-05	0.000394	CcSEcCtD
Phenytoin—Nausea—Melphalan—peripheral nervous system neoplasm	8.41e-05	0.000394	CcSEcCtD
Phenytoin—Asthma—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000392	CcSEcCtD
Phenytoin—Influenza—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000392	CcSEcCtD
Phenytoin—Dysphagia—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.000392	CcSEcCtD
Phenytoin—Dehydration—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.00039	CcSEcCtD
Phenytoin—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.31e-05	0.00039	CcSEcCtD
Phenytoin—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	8.31e-05	0.000389	CcSEcCtD
Phenytoin—Tachycardia—Etoposide—peripheral nervous system neoplasm	8.28e-05	0.000388	CcSEcCtD
Phenytoin—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	8.28e-05	0.000388	CcSEcCtD
Phenytoin—Body temperature increased—Vincristine—peripheral nervous system neoplasm	8.28e-05	0.000388	CcSEcCtD
Phenytoin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000387	CcSEcCtD
Phenytoin—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	8.26e-05	0.000387	CcSEcCtD
Phenytoin—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	8.2e-05	0.000384	CcSEcCtD
Phenytoin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000383	CcSEcCtD
Phenytoin—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	8.18e-05	0.000383	CcSEcCtD
Phenytoin—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000382	CcSEcCtD
Phenytoin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000379	CcSEcCtD
Phenytoin—Anorexia—Etoposide—peripheral nervous system neoplasm	8.09e-05	0.000379	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	8.06e-05	0.000378	CcSEcCtD
Phenytoin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.05e-05	0.000377	CcSEcCtD
Phenytoin—Bronchitis—Epirubicin—peripheral nervous system neoplasm	8.04e-05	0.000377	CcSEcCtD
Phenytoin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.02e-05	0.000376	CcSEcCtD
Phenytoin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	8.01e-05	0.000375	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	7.99e-05	0.000375	CcSEcCtD
Phenytoin—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000372	CcSEcCtD
Phenytoin—Hypotension—Etoposide—peripheral nervous system neoplasm	7.93e-05	0.000371	CcSEcCtD
Phenytoin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	7.92e-05	0.000371	CcSEcCtD
Phenytoin—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.00037	CcSEcCtD
Phenytoin—Dysuria—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000366	CcSEcCtD
Phenytoin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	7.8e-05	0.000365	CcSEcCtD
Phenytoin—Asthma—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000363	CcSEcCtD
Phenytoin—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000363	CcSEcCtD
Phenytoin—Influenza—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000363	CcSEcCtD
Phenytoin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	7.72e-05	0.000361	CcSEcCtD
Phenytoin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	7.69e-05	0.00036	CcSEcCtD
Phenytoin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000359	CcSEcCtD
Phenytoin—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000358	CcSEcCtD
Phenytoin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	7.63e-05	0.000358	CcSEcCtD
Phenytoin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	7.62e-05	0.000357	CcSEcCtD
Phenytoin—Weight decreased—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000354	CcSEcCtD
Phenytoin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.56e-05	0.000354	CcSEcCtD
Phenytoin—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000353	CcSEcCtD
Phenytoin—Somnolence—Etoposide—peripheral nervous system neoplasm	7.54e-05	0.000353	CcSEcCtD
Phenytoin—Asthenia—Vincristine—peripheral nervous system neoplasm	7.51e-05	0.000352	CcSEcCtD
Phenytoin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.5e-05	0.000351	CcSEcCtD
Phenytoin—Drowsiness—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000349	CcSEcCtD
Phenytoin—SCN1A—cerebellum—peripheral nervous system neoplasm	7.45e-05	0.0221	CbGeAlD
Phenytoin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.45e-05	0.000349	CcSEcCtD
Phenytoin—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	7.44e-05	0.000349	CcSEcCtD
Phenytoin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.44e-05	0.000348	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000346	CcSEcCtD
Phenytoin—Rash—Dactinomycin—peripheral nervous system neoplasm	7.39e-05	0.000346	CcSEcCtD
Phenytoin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000346	CcSEcCtD
Phenytoin—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000344	CcSEcCtD
Phenytoin—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000343	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.32e-05	0.000343	CcSEcCtD
Phenytoin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.32e-05	0.000343	CcSEcCtD
Phenytoin—Fatigue—Etoposide—peripheral nervous system neoplasm	7.31e-05	0.000343	CcSEcCtD
Phenytoin—Constipation—Etoposide—peripheral nervous system neoplasm	7.25e-05	0.00034	CcSEcCtD
Phenytoin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7.25e-05	0.00034	CcSEcCtD
Phenytoin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000339	CcSEcCtD
Phenytoin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.19e-05	0.000337	CcSEcCtD
Phenytoin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.17e-05	0.000336	CcSEcCtD
Phenytoin—Sweating—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.000335	CcSEcCtD
Phenytoin—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000331	CcSEcCtD
Phenytoin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.00033	CcSEcCtD
Phenytoin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000329	CcSEcCtD
Phenytoin—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7e-05	0.000328	CcSEcCtD
Phenytoin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000328	CcSEcCtD
Phenytoin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000328	CcSEcCtD
Phenytoin—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000327	CcSEcCtD
Phenytoin—Nausea—Dactinomycin—peripheral nervous system neoplasm	6.96e-05	0.000326	CcSEcCtD
Phenytoin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000326	CcSEcCtD
Phenytoin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	6.94e-05	0.000325	CcSEcCtD
Phenytoin—Dizziness—Vincristine—peripheral nervous system neoplasm	6.93e-05	0.000324	CcSEcCtD
Phenytoin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	6.91e-05	0.000324	CcSEcCtD
Phenytoin—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000323	CcSEcCtD
Phenytoin—Rash—Alitretinoin—peripheral nervous system neoplasm	6.85e-05	0.000321	CcSEcCtD
Phenytoin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.85e-05	0.000321	CcSEcCtD
Phenytoin—SCN2A—cerebellum—peripheral nervous system neoplasm	6.84e-05	0.0203	CbGeAlD
Phenytoin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.00032	CcSEcCtD
Phenytoin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.82e-05	0.00032	CcSEcCtD
Phenytoin—Bradycardia—Epirubicin—peripheral nervous system neoplasm	6.81e-05	0.000319	CcSEcCtD
Phenytoin—Headache—Alitretinoin—peripheral nervous system neoplasm	6.81e-05	0.000319	CcSEcCtD
Phenytoin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	6.78e-05	0.000318	CcSEcCtD
Phenytoin—Urticaria—Etoposide—peripheral nervous system neoplasm	6.74e-05	0.000316	CcSEcCtD
Phenytoin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.73e-05	0.000315	CcSEcCtD
Phenytoin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000314	CcSEcCtD
Phenytoin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.71e-05	0.000314	CcSEcCtD
Phenytoin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.000314	CcSEcCtD
Phenytoin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000314	CcSEcCtD
Phenytoin—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000312	CcSEcCtD
Phenytoin—Vomiting—Vincristine—peripheral nervous system neoplasm	6.66e-05	0.000312	CcSEcCtD
Phenytoin—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.64e-05	0.000311	CcSEcCtD
Phenytoin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000311	CcSEcCtD
Phenytoin—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.00031	CcSEcCtD
Phenytoin—Rash—Vincristine—peripheral nervous system neoplasm	6.6e-05	0.000309	CcSEcCtD
Phenytoin—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.6e-05	0.000309	CcSEcCtD
Phenytoin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.58e-05	0.000308	CcSEcCtD
Phenytoin—Headache—Vincristine—peripheral nervous system neoplasm	6.56e-05	0.000307	CcSEcCtD
Phenytoin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000306	CcSEcCtD
Phenytoin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000305	CcSEcCtD
Phenytoin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.47e-05	0.000303	CcSEcCtD
Phenytoin—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.46e-05	0.000302	CcSEcCtD
Phenytoin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000302	CcSEcCtD
Phenytoin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.34e-05	0.000297	CcSEcCtD
Phenytoin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000297	CcSEcCtD
Phenytoin—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000295	CcSEcCtD
Phenytoin—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	6.26e-05	0.00216	CbGpPWpGaD
Phenytoin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.25e-05	0.000293	CcSEcCtD
Phenytoin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000292	CcSEcCtD
Phenytoin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000292	CcSEcCtD
Phenytoin—Nausea—Vincristine—peripheral nervous system neoplasm	6.22e-05	0.000291	CcSEcCtD
Phenytoin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000291	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—ERBB2—peripheral nervous system neoplasm	6.2e-05	0.00214	CbGpPWpGaD
Phenytoin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.00029	CcSEcCtD
Phenytoin—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000289	CcSEcCtD
Phenytoin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000288	CcSEcCtD
Phenytoin—Asthenia—Etoposide—peripheral nervous system neoplasm	6.09e-05	0.000285	CcSEcCtD
Phenytoin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.09e-05	0.000285	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—MET—peripheral nervous system neoplasm	6.08e-05	0.0021	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—PTPN11—peripheral nervous system neoplasm	6.07e-05	0.00209	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—MET—peripheral nervous system neoplasm	6.05e-05	0.00209	CbGpPWpGaD
Phenytoin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.05e-05	0.000283	CcSEcCtD
Phenytoin—SCN3A—cerebellum—peripheral nervous system neoplasm	6.01e-05	0.0178	CbGeAlD
Phenytoin—Chills—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000281	CcSEcCtD
Phenytoin—Pruritus—Etoposide—peripheral nervous system neoplasm	6e-05	0.000281	CcSEcCtD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.98e-05	0.00206	CbGpPWpGaD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	5.96e-05	0.00206	CbGpPWpGaD
Phenytoin—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.89e-05	0.000276	CcSEcCtD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.87e-05	0.00202	CbGpPWpGaD
Phenytoin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.86e-05	0.000274	CcSEcCtD
Phenytoin—Rash—Cisplatin—peripheral nervous system neoplasm	5.84e-05	0.000274	CcSEcCtD
Phenytoin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.83e-05	0.000273	CcSEcCtD
Phenytoin—SCN4A—Axon guidance—PTPN11—peripheral nervous system neoplasm	5.83e-05	0.00201	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—PTPN11—peripheral nervous system neoplasm	5.83e-05	0.00201	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.81e-05	0.00201	CbGpPWpGaD
Phenytoin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.8e-05	0.000272	CcSEcCtD
Phenytoin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000271	CcSEcCtD
Phenytoin—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000269	CcSEcCtD
Phenytoin—Tension—Epirubicin—peripheral nervous system neoplasm	5.72e-05	0.000268	CcSEcCtD
Phenytoin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000267	CcSEcCtD
Phenytoin—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.69e-05	0.00196	CbGpPWpGaD
Phenytoin—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000265	CcSEcCtD
Phenytoin—Back pain—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000264	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—PTPN11—peripheral nervous system neoplasm	5.62e-05	0.00194	CbGpPWpGaD
Phenytoin—Dizziness—Etoposide—peripheral nervous system neoplasm	5.61e-05	0.000263	CcSEcCtD
Phenytoin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.6e-05	0.000262	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	5.6e-05	0.00193	CbGpPWpGaD
Phenytoin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000262	CcSEcCtD
Phenytoin—Chills—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.00026	CcSEcCtD
Phenytoin—Nausea—Cisplatin—peripheral nervous system neoplasm	5.5e-05	0.000258	CcSEcCtD
Phenytoin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000253	CcSEcCtD
Phenytoin—Vomiting—Etoposide—peripheral nervous system neoplasm	5.39e-05	0.000253	CcSEcCtD
Phenytoin—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.000252	CcSEcCtD
Phenytoin—Agitation—Epirubicin—peripheral nervous system neoplasm	5.35e-05	0.000251	CcSEcCtD
Phenytoin—Rash—Etoposide—peripheral nervous system neoplasm	5.35e-05	0.000251	CcSEcCtD
Phenytoin—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.34e-05	0.00025	CcSEcCtD
Phenytoin—Headache—Etoposide—peripheral nervous system neoplasm	5.31e-05	0.000249	CcSEcCtD
Phenytoin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000249	CcSEcCtD
Phenytoin—Tension—Doxorubicin—peripheral nervous system neoplasm	5.29e-05	0.000248	CcSEcCtD
Phenytoin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000247	CcSEcCtD
Phenytoin—Malaise—Epirubicin—peripheral nervous system neoplasm	5.25e-05	0.000246	CcSEcCtD
Phenytoin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000245	CcSEcCtD
Phenytoin—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000245	CcSEcCtD
Phenytoin—Syncope—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000245	CcSEcCtD
Phenytoin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000244	CcSEcCtD
Phenytoin—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.21e-05	0.000244	CcSEcCtD
Phenytoin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.18e-05	0.000243	CcSEcCtD
Phenytoin—CYP2C18—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.18e-05	0.00179	CbGpPWpGaD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	5.17e-05	0.00179	CbGpPWpGaD
Phenytoin—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000241	CcSEcCtD
Phenytoin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.12e-05	0.00024	CcSEcCtD
Phenytoin—CYP3A7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.1e-05	0.00176	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.09e-05	0.00176	CbGpPWpGaD
Phenytoin—Cough—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000238	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—GNS—peripheral nervous system neoplasm	5.06e-05	0.00175	CbGpPWpGaD
Phenytoin—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000237	CcSEcCtD
Phenytoin—Nausea—Etoposide—peripheral nervous system neoplasm	5.04e-05	0.000236	CcSEcCtD
Phenytoin—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000236	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—ERBB2—peripheral nervous system neoplasm	5.01e-05	0.00173	CbGpPWpGaD
Phenytoin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000234	CcSEcCtD
Phenytoin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	4.98e-05	0.000233	CcSEcCtD
Phenytoin—Arthralgia—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000232	CcSEcCtD
Phenytoin—Myalgia—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000232	CcSEcCtD
Phenytoin—Chest pain—Epirubicin—peripheral nervous system neoplasm	4.96e-05	0.000232	CcSEcCtD
Phenytoin—Agitation—Doxorubicin—peripheral nervous system neoplasm	4.95e-05	0.000232	CcSEcCtD
Phenytoin—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.9e-05	0.00023	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—MET—peripheral nervous system neoplasm	4.9e-05	0.00169	CbGpPWpGaD
Phenytoin—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.86e-05	0.000228	CcSEcCtD
Phenytoin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.85e-05	0.000227	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—NME1—peripheral nervous system neoplasm	4.85e-05	0.00167	CbGpPWpGaD
Phenytoin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000227	CcSEcCtD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.84e-05	0.00167	CbGpPWpGaD
Phenytoin—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000227	CcSEcCtD
Phenytoin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000226	CcSEcCtD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.81e-05	0.00166	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—ERBB2—peripheral nervous system neoplasm	4.8e-05	0.00166	CbGpPWpGaD
Phenytoin—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000225	CcSEcCtD
Phenytoin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000223	CcSEcCtD
Phenytoin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000223	CcSEcCtD
Phenytoin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.74e-05	0.000222	CcSEcCtD
Phenytoin—Infection—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000221	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—NRAS—peripheral nervous system neoplasm	4.72e-05	0.00163	CbGpPWpGaD
Phenytoin—Cough—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.00022	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—MET—peripheral nervous system neoplasm	4.68e-05	0.00162	CbGpPWpGaD
Phenytoin—Shock—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000219	CcSEcCtD
Phenytoin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000219	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—COX2—peripheral nervous system neoplasm	4.67e-05	0.00161	CbGpPWpGaD
Phenytoin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000218	CcSEcCtD
Phenytoin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000218	CcSEcCtD
Phenytoin—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000218	CcSEcCtD
Phenytoin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.64e-05	0.000217	CcSEcCtD
Phenytoin—SCN2A—Axon guidance—ERBB2—peripheral nervous system neoplasm	4.61e-05	0.00159	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—ERBB2—peripheral nervous system neoplasm	4.61e-05	0.00159	CbGpPWpGaD
Phenytoin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.6e-05	0.000215	CcSEcCtD
Phenytoin—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000215	CcSEcCtD
Phenytoin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000215	CcSEcCtD
Phenytoin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.59e-05	0.000215	CcSEcCtD
Phenytoin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.53e-05	0.000212	CcSEcCtD
Phenytoin—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000212	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	4.53e-05	0.00156	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—MET—peripheral nervous system neoplasm	4.5e-05	0.00155	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—MET—peripheral nervous system neoplasm	4.5e-05	0.00155	CbGpPWpGaD
Phenytoin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.49e-05	0.00021	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—ERBB2—peripheral nervous system neoplasm	4.44e-05	0.00153	CbGpPWpGaD
Phenytoin—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.44e-05	0.000208	CcSEcCtD
Phenytoin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.44e-05	0.000208	CcSEcCtD
Phenytoin—SCN8A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	4.42e-05	0.00153	CbGpPWpGaD
Phenytoin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.000206	CcSEcCtD
Phenytoin—Infection—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000205	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—MET—peripheral nervous system neoplasm	4.34e-05	0.0015	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000203	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	4.33e-05	0.00149	CbGpPWpGaD
Phenytoin—Shock—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000203	CcSEcCtD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.32e-05	0.00149	CbGpPWpGaD
Phenytoin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000202	CcSEcCtD
Phenytoin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000202	CcSEcCtD
Phenytoin—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000202	CcSEcCtD
Phenytoin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.29e-05	0.000201	CcSEcCtD
Phenytoin—SCN5A—Axon guidance—MET—peripheral nervous system neoplasm	4.27e-05	0.00147	CbGpPWpGaD
Phenytoin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.27e-05	0.0002	CcSEcCtD
Phenytoin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.25e-05	0.000199	CcSEcCtD
Phenytoin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.24e-05	0.000199	CcSEcCtD
Phenytoin—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.23e-05	0.000198	CcSEcCtD
Phenytoin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000197	CcSEcCtD
Phenytoin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.19e-05	0.000196	CcSEcCtD
Phenytoin—SCN4A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	4.16e-05	0.00144	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	4.16e-05	0.00144	CbGpPWpGaD
Phenytoin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000194	CcSEcCtD
Phenytoin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.11e-05	0.000193	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.11e-05	0.000192	CcSEcCtD
Phenytoin—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.000192	CcSEcCtD
Phenytoin—Constipation—Epirubicin—peripheral nervous system neoplasm	4.07e-05	0.000191	CcSEcCtD
Phenytoin—SCN1A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	4.01e-05	0.00138	CbGpPWpGaD
Phenytoin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.01e-05	0.000188	CcSEcCtD
Phenytoin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000186	CcSEcCtD
Phenytoin—SCN5A—Axon guidance—PTPN11—peripheral nervous system neoplasm	3.95e-05	0.00136	CbGpPWpGaD
Phenytoin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	3.95e-05	0.000185	CcSEcCtD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.94e-05	0.00136	CbGpPWpGaD
Phenytoin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.92e-05	0.000184	CcSEcCtD
Phenytoin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000184	CcSEcCtD
Phenytoin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.91e-05	0.000183	CcSEcCtD
Phenytoin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.87e-05	0.000181	CcSEcCtD
Phenytoin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000179	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—NRAS—peripheral nervous system neoplasm	3.82e-05	0.00132	CbGpPWpGaD
Phenytoin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.8e-05	0.000178	CcSEcCtD
Phenytoin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000178	CcSEcCtD
Phenytoin—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.78e-05	0.000177	CcSEcCtD
Phenytoin—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.77e-05	0.0013	CbGpPWpGaD
Phenytoin—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.76e-05	0.000176	CcSEcCtD
Phenytoin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000176	CcSEcCtD
Phenytoin—CYP2C18—Metabolism—GNS—peripheral nervous system neoplasm	3.74e-05	0.00129	CbGpPWpGaD
Phenytoin—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	3.71e-05	0.011	CbGeAlD
Phenytoin—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.68e-05	0.00127	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—NRAS—peripheral nervous system neoplasm	3.65e-05	0.00126	CbGpPWpGaD
Phenytoin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.00017	CcSEcCtD
Phenytoin—CYP2C18—Metabolism—NME1—peripheral nervous system neoplasm	3.59e-05	0.00124	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	3.58e-05	0.00123	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—NRAS—peripheral nervous system neoplasm	3.51e-05	0.00121	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—NRAS—peripheral nervous system neoplasm	3.51e-05	0.00121	CbGpPWpGaD
Phenytoin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.5e-05	0.000164	CcSEcCtD
Phenytoin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.5e-05	0.000164	CcSEcCtD
Phenytoin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000163	CcSEcCtD
Phenytoin—CYP2C18—Metabolism—COX2—peripheral nervous system neoplasm	3.46e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—HRAS—peripheral nervous system neoplasm	3.45e-05	0.00119	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.44e-05	0.00119	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.43e-05	0.00118	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	3.42e-05	0.00118	CbGpPWpGaD
Phenytoin—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.41e-05	0.00016	CcSEcCtD
Phenytoin—SCN1A—Axon guidance—NRAS—peripheral nervous system neoplasm	3.38e-05	0.00117	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—NRAS—peripheral nervous system neoplasm	3.37e-05	0.00116	CbGpPWpGaD
Phenytoin—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.36e-05	0.000158	CcSEcCtD
Phenytoin—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.33e-05	0.00115	CbGpPWpGaD
Phenytoin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.32e-05	0.00114	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	3.29e-05	0.00113	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	3.29e-05	0.00113	CbGpPWpGaD
Phenytoin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.25e-05	0.000152	CcSEcCtD
Phenytoin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.24e-05	0.000152	CcSEcCtD
Phenytoin—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.19e-05	0.0011	CbGpPWpGaD
Phenytoin—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.18e-05	0.0011	CbGpPWpGaD
Phenytoin—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.17e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	3.17e-05	0.00109	CbGpPWpGaD
Phenytoin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000148	CcSEcCtD
Phenytoin—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000147	CcSEcCtD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.13e-05	0.00108	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—ERBB2—peripheral nervous system neoplasm	3.12e-05	0.00108	CbGpPWpGaD
Phenytoin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.11e-05	0.000146	CcSEcCtD
Phenytoin—CYP11B1—Metabolism—ENO2—peripheral nervous system neoplasm	3.06e-05	0.00106	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.05e-05	0.00105	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—MET—peripheral nervous system neoplasm	3.05e-05	0.00105	CbGpPWpGaD
Phenytoin—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.02e-05	0.000142	CcSEcCtD
Phenytoin—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.01e-05	0.00104	CbGpPWpGaD
Phenytoin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.01e-05	0.000141	CcSEcCtD
Phenytoin—Rash—Epirubicin—peripheral nervous system neoplasm	3e-05	0.00014	CcSEcCtD
Phenytoin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3e-05	0.00014	CcSEcCtD
Phenytoin—Headache—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.00014	CcSEcCtD
Phenytoin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.91e-05	0.000136	CcSEcCtD
Phenytoin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.9e-05	0.001	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.86e-05	0.000988	CbGpPWpGaD
Phenytoin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	2.86e-05	0.000987	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.85e-05	0.000983	CbGpPWpGaD
Phenytoin—Nausea—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000132	CcSEcCtD
Phenytoin—SCN5A—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.82e-05	0.000973	CbGpPWpGaD
Phenytoin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000131	CcSEcCtD
Phenytoin—SCN9A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.79e-05	0.000963	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.78e-05	0.000959	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.78e-05	0.000958	CbGpPWpGaD
Phenytoin—Rash—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.00013	CcSEcCtD
Phenytoin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.77e-05	0.00013	CcSEcCtD
Phenytoin—Headache—Doxorubicin—peripheral nervous system neoplasm	2.76e-05	0.000129	CcSEcCtD
Phenytoin—SCN9A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.72e-05	0.000939	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.68e-05	0.000923	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.67e-05	0.000921	CbGpPWpGaD
Phenytoin—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.000122	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.6e-05	0.000899	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.6e-05	0.000896	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—BCHE—peripheral nervous system neoplasm	2.59e-05	0.000893	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.56e-05	0.000885	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.56e-05	0.000885	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.55e-05	0.000879	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.5e-05	0.000863	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.5e-05	0.000863	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GNS—peripheral nervous system neoplasm	2.49e-05	0.000859	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.49e-05	0.000859	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.47e-05	0.000853	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.47e-05	0.000852	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.46e-05	0.00085	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.45e-05	0.000845	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—TH—peripheral nervous system neoplasm	2.43e-05	0.00084	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.42e-05	0.000836	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.41e-05	0.000832	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—NME1—peripheral nervous system neoplasm	2.39e-05	0.000823	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.38e-05	0.00082	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—NRAS—peripheral nervous system neoplasm	2.38e-05	0.00082	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	2.3e-05	0.000793	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ENO2—peripheral nervous system neoplasm	2.27e-05	0.000783	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.23e-05	0.000769	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.17e-05	0.00075	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.16e-05	0.000744	CbGpPWpGaD
Phenytoin—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.14e-05	0.00074	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.99e-05	0.000687	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.99e-05	0.000686	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.95e-05	0.000673	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.92e-05	0.000664	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—BCHE—peripheral nervous system neoplasm	1.92e-05	0.000661	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.91e-05	0.000657	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.88e-05	0.000648	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.85e-05	0.000639	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.84e-05	0.000635	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.83e-05	0.000632	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.83e-05	0.000632	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.83e-05	0.000631	CbGpPWpGaD
Phenytoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.81e-05	0.000625	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—TH—peripheral nervous system neoplasm	1.8e-05	0.000622	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.8e-05	0.000621	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.79e-05	0.000618	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.78e-05	0.000615	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.76e-05	0.000609	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.76e-05	0.000609	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000607	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.75e-05	0.000605	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	1.74e-05	0.0006	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.73e-05	0.000595	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.72e-05	0.000593	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.71e-05	0.000591	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.7e-05	0.000586	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.7e-05	0.000585	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.68e-05	0.00058	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.66e-05	0.000573	CbGpPWpGaD
Phenytoin—ABCB1—cerebellum—peripheral nervous system neoplasm	1.62e-05	0.00479	CbGeAlD
Phenytoin—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000558	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000558	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.62e-05	0.000558	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.6e-05	0.000552	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.58e-05	0.000544	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.56e-05	0.000538	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.56e-05	0.000538	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.55e-05	0.000535	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.51e-05	0.00052	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.5e-05	0.000518	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.49e-05	0.000516	CbGpPWpGaD
Phenytoin—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.49e-05	0.000513	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—GNAS—peripheral nervous system neoplasm	1.47e-05	0.000508	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.46e-05	0.000503	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ABCB1—peripheral nervous system neoplasm	1.44e-05	0.000498	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.44e-05	0.000496	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.43e-05	0.000494	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.43e-05	0.000493	CbGpPWpGaD
Phenytoin—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.43e-05	0.000493	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.42e-05	0.000488	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.39e-05	0.00048	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.36e-05	0.000468	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.33e-05	0.00046	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.3e-05	0.000449	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.3e-05	0.000449	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.28e-05	0.000443	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.28e-05	0.00044	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.27e-05	0.00044	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.27e-05	0.000438	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000432	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.24e-05	0.000428	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.22e-05	0.00042	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.22e-05	0.000419	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.2e-05	0.000413	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.17e-05	0.000404	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.16e-05	0.000399	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.14e-05	0.000393	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.12e-05	0.000385	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.12e-05	0.000385	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000378	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.09e-05	0.000376	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.04e-05	0.00036	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	9.78e-06	0.000337	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	9.6e-06	0.000331	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	9.44e-06	0.000326	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	9.42e-06	0.000325	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	9.39e-06	0.000324	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	9.21e-06	0.000318	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.17e-06	0.000316	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.99e-06	0.00031	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	8.86e-06	0.000306	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.79e-06	0.000303	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	8.66e-06	0.000299	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	8.43e-06	0.000291	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	8.37e-06	0.000289	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	8.23e-06	0.000284	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.02e-06	0.000277	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	7.98e-06	0.000275	CbGpPWpGaD
Phenytoin—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	7.93e-06	0.000274	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	7.86e-06	0.000271	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.74e-06	0.000267	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.72e-06	0.000266	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.69e-06	0.000265	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.61e-06	0.000263	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.57e-06	0.000261	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	7.5e-06	0.000259	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TH—peripheral nervous system neoplasm	7.46e-06	0.000257	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	7.23e-06	0.00025	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.12e-06	0.000246	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.1e-06	0.000245	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	7.07e-06	0.000244	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.95e-06	0.00024	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	6.94e-06	0.000239	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.79e-06	0.000234	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.7e-06	0.000231	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.63e-06	0.000229	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.54e-06	0.000225	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.49e-06	0.000224	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	6.28e-06	0.000217	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.19e-06	0.000214	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	6.12e-06	0.000211	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.11e-06	0.000211	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	6.09e-06	0.00021	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	6.01e-06	0.000207	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	5.97e-06	0.000206	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.47e-06	0.000189	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—AKT1—peripheral nervous system neoplasm	5.36e-06	0.000185	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.36e-06	0.000185	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.34e-06	0.000184	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.07e-06	0.000175	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.98e-06	0.000172	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.89e-06	0.000169	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	4.8e-06	0.000166	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.59e-06	0.000158	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.28e-06	0.000148	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.09e-06	0.000141	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.05e-06	0.00014	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.03e-06	0.000139	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	3.97e-06	0.000137	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.29e-06	0.000113	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.23e-06	0.000111	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.64e-06	9.11e-05	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.95e-06	6.74e-05	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.91e-06	6.58e-05	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.65e-06	5.7e-05	CbGpPWpGaD
Phenytoin—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.64e-06	5.67e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.48e-06	5.09e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.44e-06	4.97e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.35e-06	4.64e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.87e-07	3.06e-05	CbGpPWpGaD
